about
Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathySCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmiaGuidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.Parental origin of the X chromosome in a patient with a Robertsonian translocation and Turner's syndromeExploring the elasticity and adhesion behavior of cardiac fibroblasts by atomic force microscopy indentation.Pharmacogenetics of heart failure.Sudden death associated with danon disease in women.Truncations of titin causing dilated cardiomyopathy.Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failureA new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14.Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathyCardiomyopathy, familial dilated.Dilated cardiomyopathy and muscular dystrophies: which lesson can be learned?Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy.Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes.Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group.Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy.Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.Ophthalmic manifestations of Danon disease.Arrhythmias in dilated cardiomyopathy.Cardiomyopathy and carnitine deficiencyThe challenge of cardiomyopathies in 2007.Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathyGenetics and genetic testing of dilated cardiomyopathy: a new perspective.Heart failure and personalized medicine.Improving cardiac myocytes performance by carbon nanotubes platforms.Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association.Atomic force microscopy of 3T3 and SW-13 cell lines: an investigation of cell elasticity changes due to fixation.Carbon nanotube facilitation of myocardial ablation with radiofrequency energy.Molecular genetics of dilated cardiomyopathy.Genetic factors in dilated cardiomyopathy.A mutation in the dystrophin gene selectively affecting dystrophin expression in the heartLamin A/C gene and the heart: how genetics may impact clinical care.Dilated cardiomyopathy: a genetic approach.Family members of patients with ARVC: who is at risk? At what age? When and how often should we evaluate to determine risk?Inhibition of proto-oncogene c-Src tyrosine kinase: toward a new antiarrhythmic strategy?Phenotypic heterogeneity of sarcomeric gene mutations: a matter of gain and loss?Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome.
P50
Q24306812-F0BB2646-80B3-43E4-BA40-81FADEA0C8EEQ28286219-DE33EABD-CBAF-40C6-B428-EC850C05A3A9Q33547357-B54C4761-D720-4C07-8E18-C168EBD1E32EQ33673611-2C0DD912-5F78-4422-BD11-78DB3F81E126Q33863581-60C13EC8-9D60-493E-9152-F3E291E702CAQ33986293-B71580EE-1242-4140-B94D-19579EFF7CF7Q34072434-C9DEC6B7-DA9F-43DD-BB7D-1E6FA1186000Q34254460-0F8909E8-CEB6-46A9-8317-BB10C857EC44Q34557833-479CFDB4-B7DC-4BFD-84AB-8EA839FFB7A3Q34734933-3B846BE5-498E-49BE-9278-A3EFFE6915EAQ34955215-F20966D9-2D5C-4F19-ADA5-5670EB2B91E0Q34974147-DB693350-BC51-4CF4-A924-3226F9DA3DDCQ35015924-DB5232FB-1BA4-4B9A-BF20-3C56787DCCC7Q35032817-686D1D30-D7AB-477C-8A4D-CE00850595E4Q35036043-217A8F00-F42F-48C6-9A02-AC8966E7ADAAQ35197101-9DEF0173-EFBB-4D2B-A696-F9CB17420AB4Q35623368-617D5310-87C0-4549-92F2-15322BAF1193Q35644386-6792EEBD-718E-4F99-9DFD-2A941B1C9350Q35843134-3020D4E1-EBC9-4B23-96C6-7EC1FE18AE03Q35990104-2094B784-6427-43C4-BF30-0F2CAA5683D4Q36496411-B7F0740C-0433-49CC-B80A-5945574C06BAQ36707257-CA5A2BDC-9AB3-4A53-964C-9607E237F49DQ36725320-73C59454-A874-4630-AE27-FD31D0E10691Q37162074-A76981EE-2F67-4CA1-B6C7-F0A1E7BFF274Q37397192-9D71380A-E007-4D62-82ED-20E9C10858B8Q37594505-1D6C3754-F15D-4DAC-B500-F2DD72536AECQ37784979-6628C7BD-CB23-4560-8D1A-434729F01179Q38136642-3C42B4F7-D7EF-429F-B987-A339910EE34AQ38168149-66BF34A3-E195-46A1-8E7E-B4E99B2A72B5Q39147827-D9BC4CC0-AE9C-4701-A1D1-F3A6C84C22DCQ40212518-71FF7402-570E-4D36-B4DA-535955C0DB87Q40758141-64F56A3E-0AAC-49F9-9EB4-5AC369AFE85DQ41176839-5BA41D37-DE99-4728-A7A1-B30C7E6E8D8AQ41968446-0BBF2FDC-1993-4976-AB1B-2269C746A33DQ41972456-AED01866-186A-40B6-91CC-3E72211E5184Q42390693-05EBF5F8-9952-40A3-8697-13EEA36882CAQ42427498-8CB2DEFE-AAB5-44B3-95EE-CD94AAE5BC9DQ42429460-685A8C58-5AF3-4A44-847F-9A06DF654D92Q42576065-BC4E32DA-921E-461C-9CDB-CAF4C61A141AQ43442657-B74B2718-3062-406F-A653-45C6C798BB5B
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Luisa Mestroni
@ast
Luisa Mestroni
@en
Luisa Mestroni
@es
Luisa Mestroni
@nl
Luisa Mestroni
@sl
type
label
Luisa Mestroni
@ast
Luisa Mestroni
@en
Luisa Mestroni
@es
Luisa Mestroni
@nl
Luisa Mestroni
@sl
prefLabel
Luisa Mestroni
@ast
Luisa Mestroni
@en
Luisa Mestroni
@es
Luisa Mestroni
@nl
Luisa Mestroni
@sl
P214
P244
P106
P21
P214
P244
n2013181254
P2798
P31
P3762
P496
0000-0003-1116-2286
P735
P7859
lccn-n2013181254